To: Sarepta Therapeutics, Inc. 215 First Street, Suite 415 Cambridge, MA 02142 Attention: General Counsel Telephone No.: (617) 274-4000 A/C: 052201829 From: Goldman Sachs & Co. LLC Re: Base Call Option Transaction Date: November 8, 2017